CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma
CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma PR Newswire ROCKVILLE, Md. and BEIJING , June 10, 2021 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: more...
Cocrystal Pharma’s Participation in the Noble Capital Markets C-Suite Interview Series is Now Available Online
BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, more...
Love Hemp Group PLC Announces Issue of Warrants and Issue of Equity
LONDON, ENGLAND / ACCESSWIRE / June 9, 2021 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces the issue of warrants and equity by the Company. Issue more...
What Makes Opexa Therapeutics, Inc. (ACER) a New Buy Stock
Opexa Therapeutics, Inc. (ACER) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates — one more...
Aclaris (ACRS) Announces Data on Atopic Dermatitis Candidate
Aclaris Therapeutics, Inc. ACRS announced positive preliminary top-line data from the first in-human phase IIa study evaluating its JAK 1/3 inhibitor, ATI-1777, for the treatment of moderate-to-severe atopic dermatitis (“AD”). The multicenter, double-blind, parallel-group study more...
Strength Seen in ARIDIS PHARMACT (ARDS): Can Its 10% Jump Turn into More Strength?
ARIDIS PHARMACT (ARDS) shares soared 10% in the last trading session to close at $6.85. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares more...
What Stocks To Buy Today? 4 Health Care Stocks To Know
Are These The Top Health Care Stocks To Buy Now? Health care stocks may not be as hot as they were in the stock market back in 2020. However, there are always hidden gems waiting more...
Atossa Therapeutics Announces Final Data from Phase 2 Endoxifen Breast Cancer Study Primary Endpoint Met: 65.1% Reduction in Biomarker Ki-67; Secondary Endpoint Met: Endoxifen Safe and Well Tolerated
SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on more...
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
BERKELEY HEIGHTS, N.J., June 09, 2021 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced more...
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
WARREN, N.J., June 09, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that more...